Other Pharmacology, Toxicology and Environmental Health Commons^™

Map The System: Presence And Impact Of Ppcps In Water, Emma Vandermeulen, Ruby Mitchell

OHSU-PSU School of Public Health Annual Conference

In a changing climate, there is growing emphasis on protecting our water sources and developing systems for conserving and reusing water. While many contaminants of concern are monitored and addressed by water treatment systems, pharmaceuticals and personal care products (PPCPs) are generally not accounted for. PPCPs in water systems have been an increasing concern as detection of these products has increased over the last few decades. Studies have been exploring the impact of antibiotics, antidepressants, contraceptives, and other anthropogenic products on our water system and how these substances interact with local ecosystems. Our main research questions are to understand what …

Lc-Ms/Ms Method For The Detection And Quantification Of Pharmaceuticals And Drugs Of Abuse In New York City Waterways, Natalie M. Fernandez

Student Theses

The use of licit and illicit drugs has been increasing significantly over the past few years within the United States. Due to this increase, these drugs are emerging as contaminants in surface and ground water. The presence of pharmacologically active compounds in this environment can be extremely harmful to aquatic life as they are continuously exposed to these substances. The goal of this study was two-fold: 1) Develop and validate an analytical method for 28 different drugs including cocaine, amphetamines, opioids, cannabis, and prescription medicines, in river water; 2) Identify and quantify drugs found in New York City waterways over …

Anticoagulant Half-Life Of Heparin In Human Subjects With Normal And Impaired Renal Function., Paul James Perry

University of the Pacific Theses and Dissertations

Numerous investigators have noted that individuals vary widely in their response to the anticoagulant, heparin. Animal model3 have suggested that patients with depressed renal function would be expected to clear heparin from the blood at a slower rate than patients with normal renal function.

Utilizing the Activated Coagulation Time clotting test, a method was developed to determine the anticoagulant half-life of heparin. The study calculated the half-life of heparin in a group of individuals with normal renal function and a population of patients in chronic renal failure. Intravenous heparin doses of 0,3 units/ml and 0.6 units/ml of blood were administered …